達(dá)比加群酯

中文同義詞: 甲磺酸達(dá)比加群酯;達(dá)比加群酯甲璜酸鹽;達(dá)比加群酯甲磺酸鹽;達(dá)比加群酯甲磺酸;抗血栓藥 達(dá)比加群中間體,甲磺酸達(dá)比加群酯;3-[[[2-[[[4-[[[(己氧基)羰基] 氨基] 亞氨甲基] 苯基] 氨基] 甲基]-1-甲基-1H- 苯并咪唑-5-基] 羰基]( 吡啶-2-基) 氨基] 丙酸乙酯甲磺酸鹽

英文名稱(chēng): N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester monomethanesulfonat

英文同義詞: Dabigatran etexilate mesylate;N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester monomethanesulfonat;Pradaxa;(E)-hexyl 2-(4-((5-((3-ethoxy-3-oxopropyl)(pyridin-2-yl)carbaMoyl)-1-Methyl-1H-benzo[d]iMidazol-2-yl)MethylaMino)benzylidene)hydrazinecarboxylate Methanesulfonate;N-[[2-[[[4-[[[(Hexyloxy)carbonyl]aMino]iMinoMethyl]phenyl]aMino]Methyl]-1-Methyl-1H-benziMidazol-5-y;BIBR 1048MS;N-[[2-[[[4-[[[(Hexyloxy)carbonyl]aMino]iMinoMethyl]phenyl]aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine Ethyl Ester Methanesulfonate;Dabigatran etexilate Methanesulfonate

CAS號(hào): 872728-81-9

分子式: C34H41N7O5.CH4O3S

分子量: 723.84

相關(guān)類(lèi)別: Aromatics;Bases & Related Reagents;Heterocycles;Intermediates & Fine Chemicals;Nucleotides;Pharmaceuticals;Dabigatran etexilate mesylate;達(dá)比加群酯甲磺酸鹽

Application:是一種新型口服抗凝血藥物，屬非肽類(lèi)的凝血酶抑制劑，通過(guò)特異性和選擇性地阻斷凝血酶（游離型或結(jié)合型）的活性而發(fā)揮抗凝效果。